Human gastric adenocarcinoma allelotype on chromosomes 17 and 18

Journal of International Medical Research

Volumn 36, Issue 2, 2008, Pages 279-288

  Yu, J C ^a   Zhou, H ^b   Bai, J ^a   Yu, Y ^a   Geng, J S ^a   Qi, J P ^a   Fu, Song Bin ^a,c  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c Bio pharmaceutical Key Laboratory of Heilongjiang Province   (China)

Author keywords

Gastric adenocarcinoma; Genome wide search; Loss of heterozygosity; Tumour suppressor genes

Indexed keywords

GENOMIC DNA;

ALLELE; ARTICLE; CHROMOSOME 17; CHROMOSOME 18; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; GENE DELETION; GENE INACTIVATION; GENE LOCUS; GENE MAPPING; GENOME ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MICROSATELLITE MARKER; PROMOTER REGION; STOMACH ADENOCARCINOMA; STOMACH CARCINOGENESIS; TISSUE SECTION; TUMOR SUPPRESSOR GENE;

EID: 42049087830     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000803600210     Document Type: Article

References (35)

1. Pan CJ, Liu KY: Proliferation/opoptosis and expression of p53 and Bcl-2 in gastric carcinoma. Shi Jie Hua Ren Xiao Hua Za Zhi 2003; 11: 526-530.
2. Kobayashi M, Kawashima A, Mai M, et al: Analysis of chromosome 17p13 (p53 locus) alterations in gastric carcinoma cells by dual-color fluorescence in situ hybridization. Am J Pathol 1996; 149: 1575-1584.
3. Fenoglio-Preiser CM, Wang J, Stemmermann GN, et al: TP53 and gastric carcinoma: a review. Hum Mutat 2003; 21: 258-270.
4. Semba S, Yokozaki H, Yasui W, et al: Frequent microsatellite instability and loss of heterozygosity in the region including BRCA1(17q21) in young patients with gastric cancer. Int J Oncol 1998; 12: 1245-1251.
5. Petty EM, Kalikin LM, Orringer MB, et al: Distal chromosome 17q loss in Barrett's esophageal and gastric cardia adenocarcinomas: implications for tumorigenesis. Mol Carcinog 1998; 22: 222-228.
6. Nishioka N, Yushiro M, Inoue T, et al: A candidate tumor suppressor locus for scirrhous gastric cancer at chromosome 18q12.2. Int J Oncol 2001; 18: 317-322.
7. Nishizuka S, Tamura G, Maesawa C, et al: Analysis of the DPC4 gene in gastric carcinoma. Jpn J Cancer Res 1997; 88: 335-339.
8. Sato K, Tamura G, Tsuchiya T, et al: frequent loss of expression without sequence mutations of the DCC gene in primary gastric cancer. Br J Cancer 2001; 85: 199-203.
9. Inoue T, Uchino S, Shiraishi N, et al: Loss of heterozygosity on chromosome 18q in cohesive-type gastric cancer is associated with tumor progression and poor prognosis. Clin Cancer Res 1998; 4: 973-977.
10. de Manzoni G, Tomezzoli A, Di Leo A, et al: Clinical significance of mutator phenotype and chromosome 17p and 18q allelic loss in gastric cancer. Br J Surg 2001; 88: 419-425.
11. Roy D, Calaf G, Hei TK: Frequent allelic imbalance on chromosome 6 and 17 correlate with radiation-induced neoplastic trans form ati on of human breast epithelial cells. Carcinogenesis 2001; 22: 1685-1692.
12. Kubo H, Miki C, Kusunoki M: Evaluation of genetic mutations of tumor suppresser genes in colorectal cancer patients. Hepatogastroenterology 2004; 51: 114-117.
13. Ko JM, Wong CP, Tang CM, et al: Frequent loss of heterozygosity on multiple chromosomes in Chinese esophageal squamous cell carcinomas. Cancer Lett 2001; 170: 131-138.
14. Veltman JA, van Weert I, Aubele M, et al: Specific steps in aneuploidization correlate with loss of heterozygosity of 9p21, 17p13 and 18q21 in the progression of pre-malignant laryngeal lesions. Int J Cancer 2001; 91: 193-199.
15. Chae KS, Ryu BK, Lee MG, et al: Expression and mutation analyses of MKK4, a candidate tumour suppressor gene encoded by chromosome 17p, in human gastric adenocarcinoma. Eur J Cancer 2002; 38: 2048-2057.
16. Su GH, Hilgers W, Shekher MC, et al: Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene. Cancer Res 1998; 58: 2339-2342.
17. Tsuchiya E, Tanigami A, Ishikowa Y, et al: Three rnew regions on chromosome 17p13.3 distal to p53 with possible tumor suppressor gene involvement in lung cancer. Jpn J Cancer Res 2000; 91: 589-596.
18. Phillips NJ, Ziegler MR, Radford DM, et al: Allelic deletion on chromosome 17p13.3 in early ovarian cancer. Cancer Res 1996; 56: 606-611.
19. Nigro CL, Venesio T, Reymond A, et al: The human ROX gene: genomic structure and mutation analysis in human breast tumors. Genomics 1998, 49: 275-282.
20. Steichen-Gersdorf E, Baumgartner M, Kreczy A, et al: Deletion mapping on chromosome 17p in medulloblastoma. Br J Cancer 1997; 76: 1284-1287.
21. Wang D, Fang D, Lou Y: A study on the loss of heterozygosity at 17p13.3 and abnormal expression of p53 protein in gastric carcinoma. Zhonghua Bing Li Xue Za Zhi 1997; 26: 134-136.
22. Schultz DC, Vanderveer L, Berman DB, et al: Identification of two candidate tumor suppressor genes on chromosome 17p13.3. Cancer Res 1996; 56: 1997-2002.
23. Fujii H, Biel MA, Zhou W, et al: Methylation of HIC-1 candidate tumor suppressor gene in human breast cancer. Oncogene 1998; 16: 2159-2164.
24. Wales MM, Biel MA, Deiry WE, et al: p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat Med 1995; 1: 570-577.
25. Nigro CL, Venesio T, Reymond A, et al: The human ROX gene: genomic structure and mutation analysis in human breast tumors. Genomics 1998; 49: 275-282.
26. Gleeson CM, Sloan JM, McManus DT, et al: Comparison of p53 and DNA content abnormalities in adenocarcinoma of the oesophagus and gastric cardia. Br J Cancer 1998; 77: 277-286.
27. Fong KM, Kida Y, Zimmerman PV, et al: Loss of heterozygosity frequently affects chromosome 17q in non-small cell lung cancer. Cancer Res 1995; 55: 4268-4272.
28. 1 and p53 genes in human colorectal carcinomas. Cancer 1994; 73: 2913-2921.
29. Ji SQ, Hua YW, Zhuang J, et al: Significance of COX-2, p53, proliferating cell nuclear antigen and nm23 expressions in gastric cancer and its behavior. Ai Zheng 2002; 21: 619-624.
30. Wu CL, Kirley SD, Xiao H, et al: Cables enhances cdk2 tyrosine 15 phosphorylation by Wee1, inhibits cell growth, and is lost in many human colon and squamous cancers. Cancer Res 2001, 61: 7325-7332.
31. Tan D, Kirley S, Li Q, et al: Loss of cables protein expression in human non-small cell lung cancer: a tissue microarray study. Hum Pathol 2003, 34: 143-149.
32. Candusso ME, Lumetti o, Villani L, et al: Loss of heterozygosity at 18q21 region in gastric cancer involves a number of concer-related genes and correlates with stage and histology, but lacks independent prognostic value. j Pathol 2002; 197: 44-50.
33. Zhu YQ Yin HR, Zhu ZG, et al: Loss of heterozygosity of SMAD4/DPC4 in gostric carcinoma. Shi jie Hua Ren Xiao Hua Za Zhi 2003; 11: 522-525.
34. Takebayashi S, Ogawo T, Jung KY, et al: Identification of new minimally lost regions on 18q in head and neck squamous cell carcinoma. Cancer Res 2000; 60: 3397-3403.
35. Lassus H, Salovaara R, Aaltonen LA, et al: Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCC. Am J Pathol 2001; 159: 35-4.